EcoDrugPlus

Protein Kinase C Gamma

Ensembl ID : ENSMMMG00000003989
Gene Symbol: PRKCG
3 Cross references
198 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSMMMG00000006916
Gene Symbol: PRKCI
3 Cross references
150 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSMMMG00000016262
Gene Symbol: PRKCQ
3 Cross references
203 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSMMMG00000019084
Gene Symbol: PRKCZ
3 Cross references
201 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSMMMG00000009545
Gene Symbol: PRKD1
3 Cross references
204 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSMMMG00000017166
Gene Symbol: PRKD3
2 Cross references
269 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Alpha

Ensembl ID : ENSMMMG00000021903
Gene Symbol: PRKACA
3 Cross references
283 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Beta

Ensembl ID : ENSMMMG00000009169
Gene Symbol: PRKACB
2 Cross references
285 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSMMMG00000022087
Gene Symbol: PRKDC
3 Cross references
184 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSMMMG00000008469
Gene Symbol: PPP3CA
3 Cross references
230 Possible Orthologues:

Protein Tyrosine Kinase 2

Ensembl ID : ENSMMMG00000005381
Gene Symbol: PTK2
3 Cross references
326 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta

Ensembl ID : ENSMMMG00000013250
Gene Symbol: PTK2B
3 Cross references
269 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).